Be able to describe alterations in cholinergic neurotransmission in Alzheimer's disease.
Level
This learning outcome is a primary level outcome.
Assessment
This learning outcome is assessed in the following ways:
- NOT YET CATEGORISED
GMC theme
This learning outcome maps to the following GMC theme:
- 8q: Pathology
